Wednesday - December 10, 2025

ATNM-400 Targets B7-H3 and Is Being Studied in a Phase 1 Clinical Trial in South Africa

Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) is expanding its radiotherapeutic platform beyond hematologic cancers with ATNM-400, a next-generation candidate designed to deliver targeted radiation against B7-H3, an immune-checkpoint molecule highly expressed across multiple solid tumors. B7-H3 overexpression is linked to … Continue reading

Myseum (NASDAQ: MYSE) USPTO Patent Issued for “Picture Party” as CEO Amplifies Vision on The Street Podcast More Inside

Myseum, Inc. (NASDAQ: MYSE), a leader in digital privacy and next-generation social media technology, announced that the USPTO has issued a Notice of Allowance for its patent titled “Time Bound Event Creation and Management Based on User Specific Media Permissions.” … Continue reading

Serenities BnB Opens Limited Spots for New Host Partners, Bringing Boutique Airbnb/STR Management to Owners Seeking Higher Returns and Peace of Mind

Serenities BnB, a boutique Airbnb and short-term rental management company, with over a decade of hands-on hosting experience, has officially opened its doors to welcome a select number of new property owner clients. This rare opportunity is aimed at hosts … Continue reading